Allecra Therapeutics (United States)

Allecra Therapeutics is a biopharmaceutical company developing novel antibiotics to combat antimicrobial resistance (AMR). The company focuses on treatments for serious bacterial infections caused by multidrug-resistant gram-negative pathogens including carbapenem-resistant Enterobacteriaceae (CRE) and extended-spectrum beta-lactamase (ESBL) producing bacteria. Allecra addresses the critical global health threat of antibiotic-resistant infections in hospital settings.